Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.49 |
| ▸ | GNPAT | O15228 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | ALB | P02768 | 3/20 | 0.44 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SIRT5 | Q9NXA8 | 3/20 | 0.42 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6026003 | 1.00 | FOLH1 (0.49) | FOLH1GNPATSMN1; SMN2KDM4EMAPT | |
| SCHEMBL30526285 | 1.00 | FOLH1 (0.49) | FOLH1GNPATSMN1; SMN2KDM4EMAPT | |
| SCHEMBL446929 | 1.00 | FOLH1 (0.49) | FOLH1GNPATSMN1; SMN2KDM4EMAPT | |
| Acetic Acid SCHEMBL28406175 | 0.98 | FOLH1 (0.48) | FOLH1GNPATSMN1; SMN2KDM4EMAPT | |
| SCHEMBL9438405 | 0.98 | FOLH1 (0.48) | FOLH1GNPATSMN1; SMN2KDM4EMAPT | |
| Water SCHEMBL29401510 | 0.98 | FOLH1 (0.48) | FOLH1GNPATSMN1; SMN2KDM4EMAPT | |
| Hydrochloric Acid SCHEMBL4422480 | 0.98 | FOLH1 (0.48) | FOLH1GNPATSMN1; SMN2KDM4EMAPT | |
| SCHEMBL468736 | 0.95 | FOLH1 (0.55) | FOLH1GNPATSMN1; SMN2KDM4EMAPT | |
| SCHEMBL22769501 | 0.95 | FOLH1 (0.55) | FOLH1GNPATSMN1; SMN2KDM4EMAPT | |
| SCHEMBL29550463 | 0.95 | FOLH1 (0.55) | FOLH1GNPATSMN1; SMN2KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3615069-B1 | N-ACETYLATED AND NON-ACETYLATED DIPEPTIDES CONTAINING ARGININE TO REDUCE THE VISCOSITY OF VISCOUS COMPOSITIONS OF THERAPEUTIC POLYPEPTIDES | AMGEN INC (US) | 2025-05-28 | — | — | EP | claimed |
| EP-4537111-A2 | MULTI-OMICS ASSESSMENT | Prognomiq Inc (US) | 2025-04-16 | — | — | EP | claimed |
| CN-119816897-A | Multiple study assessment | 普罗科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| US-12103979-B2 | N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides | AMGEN INC. (US) | 2024-10-01 | — | — | US | claimed |
| WO-2023240046-A2 | MULTI-OMICS ASSESSMENT | PrognomIQ, Inc. (US) | 2023-12-14 | — | — | WO | claimed |
| US-11833127-B2 | Compositions and methods for the treatment of fat infiltration in muscle | AXCELLA HEALTH INC. (US) | 2023-12-05 | — | — | US | claimed |
| CN-116898955-A | Liquid pharmaceutical composition containing teriparatide with excellent stability | 旭化成制药株式会社 | 2023-10-20 | — | — | CN | claimed |
| US-20230038163-A1 | AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF POST-ACUTE SEQUELAE OF COVID-19 | AXCELLA (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC | 2023-02-09 | — | — | US | claimed |
| WO-2022266480-A1 | METHODS OF PREDICTING LIVER FAT CONTENT AND USES THEREOF | AXCELLA HEALTH INC. (US) | 2022-12-22 | — | — | WO | claimed |
| US-11129804-B2 | Amino acid compositions and methods for the treatment of liver diseases | AXCELLA HEALTH INC. (US) | 2021-09-28 | — | — | US | claimed |
| US-6951842-B2 | Compositions providing for increased IGF-I solubility | CHIRON CORPORATION (US) | 2005-10-04 | — | — | US | claimed |
| EP-1570840-A2 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2005-09-07 | — | — | EP | claimed |
| US-20050171194-A1 | Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions | YU RUEY J (US) | 2005-08-04 | — | — | US | claimed |
| US-20040209815-A1 | Compositions providing for increased IGF-I solubility | CHIRON CORPORATION | 2004-10-21 | — | — | US | claimed |
| US-6767892-B1 | INSULIN-LIKE GROWTH FACTOR-1 IS SOLUBILIZED WITH GUANIDINIUM COMPOUND | CHRION CORPORATION | 2004-07-27 | — | — | US | claimed |
| US-6524593-B1 | Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails | TRISTRATA, INC. | 2003-02-25 | — | — | US | claimed |
| US-6159485-A | COSMETICS; SKIN DISORDERS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-12-12 | — | — | US | claimed |
| WO-2000040217-B1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-10-05 | — | — | WO | claimed |
| EP-0673432-B1 | PROCESS FOR PREPARING CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 1999-03-24 | — | — | EP | claimed |
| EP-0736770-A2 | An immunoreactive conjugate, method for its preparation, antibodies to said conjugate and a pharmaceutical composition and diagnostic device containing them | ANDA BIOLOGICALS S.A. (FR) | 1996-10-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12103979-B2 | N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides | ARGLU1, PNISR, DNPEP | FOLH1 140/4885GNPAT 1820/4885SMN1; SMN2 1042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.